Medinotec (MDNC) Net Equity Issued and Repurchased (2022 - 2023)
Medinotec's (MDNC) quarterly Net Equity Issued and Repurchased came in at -$169375.0 in Q1 2023, down 1793.75% on a YoY basis from $10000.0 in Q1 2022, and down 200.0% quarter-over-quarter from $169375.0 in Q3 2022.
Powered by 
Analysis
Medinotec (MDNC) Net Equity Issued and Repurchased (2022 - 2023) Analysis & Trends
Medinotec (MDNC) has reported Net Equity Issued and Repurchased for 2 consecutive years, with -$169375.0 the latest figure, recorded in Q1 2023.
- For the quarter ending Q1 2023, Net Equity Issued and Repurchased fell 1793.75% year-over-year to -$169375.0; the trailing twelve-month figure through Feb 2023 stood at $3.3 million (changed N/A YoY), and the FY2023 full-year result was $3.3 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased slipped to -$169375.0 in Q1 2023 per MDNC's latest filing, from $169375.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $3.3 million in Q2 2022 and bottomed at -$169375.0 in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Feb 28, 2023 | -169,375.00 |
| Aug 31, 2022 | 169,375.00 |
| May 31, 2022 | 3.30 Mn |
| Feb 28, 2022 | 10,000.00 |